イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

part viiid drug tariff special order - flunarizine dihydrochloride - oral capsule - 5mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

part viiid drug tariff special order - flunarizine dihydrochloride - oral tablet - 10mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - flunarizine dihydrochloride - oral tablet - 5mg

イギリス - 英語 - MHRA (Medicines & Healthcare Products Regulatory Agency)

special order - flunarizine dihydrochloride - oral tablet - 20mg

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse: flunazine (flunixin meglumine injection) is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle: flunazine (flunixin meglumine injection) is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. flunazine is also indicated for the control of inflammation in endotoxemia. contraindications horse: there are no known contraindications to this drug when used as directed. intra-arterial injection should be avoided. horses inadvertently injected intra-arterially can show adverse reactions. signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness. signs are transient and disappear without antidotal medication within a few minutes. do not use in horses showing hypersensitivity to flunixin meglumine. cattle: nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use flunazine (flunixin meglumine injection) within 48 hours of expected parturition. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration are suspected.

シンガポール - 英語 - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - sumatriptan succinate eqv sumatriptan - injection - 6 mg/0.5 ml - sumatriptan succinate eqv sumatriptan 6 mg/0.5 ml

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

emcure nz limited - sumatriptan succinate 16.8 mg/ml equivalent to sumatriptan 12 mg - solution for injection - 6 mg/0.5ml - active: sumatriptan succinate 16.8 mg/ml equivalent to sumatriptan 12 mg excipient: nitrogen sodium chloride water for injection - indicated for the acute relief of migraine attacks with or without aura

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 100 ml - indication flunazine-s (flunixin meglumine injection) is indicated for the control of pyrexia associated with swine respiratory disease. contraindications there are no known contraindications to this drug in swine when used as directed. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration is suspected.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

janssen-cilag ltd - flunarizine dihydrochloride - tablet - 5 milligram(s) - antivertigo preparations; flunarizine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

janssen sciences ireland uc - flunarizine dihydrochloride - tablet - 5 milligram(s) - antivertigo preparations; flunarizine